Comments on: All Approved Indications of Five Akeso’s Innovative Drugs Included in China’s Latest NRDL: Featuring Two First-in-Class Bispecifics with New First-Line Indications and Three Newly Negotiated Drugs

Comments on: All Approved Indications of Five Akeso’s Innovative Drugs Included in China’s Latest NRDL: Featuring Two First-in-Class Bispecifics with New First-Line Indications and Three Newly Negotiated Drugs https://9krapalm.com/all-approved-indications-of-five-akesos-innovative-drugs-included-in-chinas-latest-nrdl-featuring-two-first-in-class-bispecifics-with-new-first-line-indications-and-three-newly-negotiated-drugs/ เสิร์ฟข่าวไอที อัปเดตเทคโนโลยีสไตล์ @krapalm Sun, 07 Dec 2025 06:58:19 +0000 hourly 1 https://wordpress.org/?v=7.0.4